Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
D M Ji
Observed name:
Dongmei Ji
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0003-0647-0153
Observed ORCID:
0000-0003-0647-0153
OpenAlex ID:
A5121136283
First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC
2026
·
Dongmei Ji
, Wenmin Fu
, et al.
·
BMC Medicine
·
14
LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial
2026
·
Jun Cai
, Baitian Zhao
, et al.
·
Clinical Cancer Research
[Treatment outcomes and prognostic analysis of 882 cases of poorly differentiated/anaplastic thyroid carcinoma in China: a multicenter study].
2025
·
T Lyu
, Y L Wang
, et al.
·
PubMed
Show more works
View as search
Works count:
3
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type